Trovagene, Inc. Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Trovagene (TROV) Misses Q2 EPS by 17c
August 10, 2015 4:16 PM EDTTrovagene (NASDAQ: TROV) reported Q2 EPS of ($0.41), $0.17 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $50 thousand versus the consensus estimate of $30 thousand.
"Our pilot commercial team has gained impressive traction in the field, delivering stronger than expected participation by... More
